Arima Genomics Announces Data Presentation at the Association for Molecular Pathology 2025

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced it will be presenting new data ...

Not-so-model behavior: Popular software tools may give faulty forecasts

Some of the models used to forecast everything from financial trends to animal populations in an ecosystem are incorrect, ...
Phys.org

New software simulates cancer cell behavior using genomics and computational models

In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...
360Dx

Arima Genomics Aims to Replace Some FISH-Based Cancer Tests With Hi-C Sequencing Assays

The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.
ascopubs.org

Forecasting incidence and mortality rates of bladder cancer in older adults using autoregressive integrated moving average (ARIMA).

Impact of trimodal therapy on survival outcomes in non-urothelial muscle-invasive bladder cancer: A nationwide analysis.
ascopubs.org

Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...